MedTrace Logo

Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

NCT01007357 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-07-14

No results posted yet for this study

Summary

This project will facilitate the optimization of body MR imaging at 3 Tesla.

Conditions

  • Diffuse and Focal Abnormalities of the Liver and Pancreas

Interventions

DEVICE

Body MR imaging

Body MR imaging will be performed to optimize sequences

Sponsors & Collaborators

  • Philips Medical Systems

    collaborator INDUSTRY

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Shahid Hussain, MD · University of Nebraska

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-15
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01007357 on ClinicalTrials.gov